Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
The enteral and parenteral medical nutrition market size is expected to grow from US$ 17.34 billion in 2022 to US$ 25.47 billion by 2028; it is estimated to record a CAGR of 6.8% from 2023 to 2028.
The enteral and parenteral medical nutrition market growth is attributed to the rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.
There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral and parenteral medical nutrition market.
Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral and parenteral medical nutrition market growth in the future.
Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients’ health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral and parenteral medical nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity.
Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.
Age Group -Based Insights
Based on age group, the enteral and parenteral medical nutrition market is categorized into above 60 years, 18-60 years, 3-18 years, and below 3 years. In 2022, the above 60 years segment accounted for the largest share in enteral and parenteral medical nutrition market. However, the 18-60 years segment is anticipated to register the highest CAGR during the forecast period. Weight loss and malnutrition are common in people aged above 60 years. With increasing age, the immunity of the older population decreases, and they become more prone to diseases that may deteriorate their health. Due to this, doctors prescribe external nutrition to maintain immunity and weight. According to several studies published in PubMed Central, the prevalence of chronic diseases and disabilities is significantly higher among geriatric people, generating the need for home-based treatments. Also, as per the Population Reference Bureau (2019), it is estimated that the senior population of the US is expected to grow from 52 million in 2018 to 95 million by 2060. The need for home therapy has increased due to the growing demand for home care owing to disability among old age groups. Thus, the increasing geriatric population base is expected to promote the growth of segment in the enteral and parenteral medical nutrition market.
The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral and parenteral medical nutrition market report.
The enteral and parenteral medical nutrition market growth is attributed to the rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.
There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral and parenteral medical nutrition market.
Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral and parenteral medical nutrition market growth in the future.
Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients’ health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral and parenteral medical nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity.
Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.
Age Group -Based Insights
Based on age group, the enteral and parenteral medical nutrition market is categorized into above 60 years, 18-60 years, 3-18 years, and below 3 years. In 2022, the above 60 years segment accounted for the largest share in enteral and parenteral medical nutrition market. However, the 18-60 years segment is anticipated to register the highest CAGR during the forecast period. Weight loss and malnutrition are common in people aged above 60 years. With increasing age, the immunity of the older population decreases, and they become more prone to diseases that may deteriorate their health. Due to this, doctors prescribe external nutrition to maintain immunity and weight. According to several studies published in PubMed Central, the prevalence of chronic diseases and disabilities is significantly higher among geriatric people, generating the need for home-based treatments. Also, as per the Population Reference Bureau (2019), it is estimated that the senior population of the US is expected to grow from 52 million in 2018 to 95 million by 2060. The need for home therapy has increased due to the growing demand for home care owing to disability among old age groups. Thus, the increasing geriatric population base is expected to promote the growth of segment in the enteral and parenteral medical nutrition market.
The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral and parenteral medical nutrition market report.
1. INTRODUCTION
LIST OF TABLES
LIST OF FIGURES
Figure 1. Enteral and Parenteral Medical Nutrition Market Segmentation
Figure 2. Enteral and Parenteral Medical Nutrition Market, By Region
Figure 3. Global Enteral and Parenteral Medical Nutrition Market Overview
Figure 4. Elderly Segment Held Largest Share of Indication Segment in Enteral and Parenteral Medical Nutrition Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Enteral and Parenteral Medical Nutrition Market, by Geography (US$ Million)
Figure 7. Global Enteral and Parenteral Medical Nutrition Market- Leading Country Markets (US$ Million)
Figure 8. Global Enteral and Parenteral Medical Nutrition Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis
Figure 16. Global Enteral and Parenteral Medical Nutrition Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Enteral and Parenteral Medical Nutrition Market– By Geography Forecast and Analysis – 2022 & 2028
Figure 18. Market Positioning of Key Players in Enteral and Parenteral Medical Nutrition Market
Figure 19. Market Share Analysis of Key Players in Enteral and Parenteral Medical Nutrition Market (2022)
Figure 20. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
Figure 21. Elderly: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. IBD: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. IBS: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Diabetes: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Cancer: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Alzheimer’s Disease: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Dementia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Renal Disease: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Liver Failure: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Post COVID-19: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Other Indications: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
Figure 36. Supplemental: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Sole Source: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
Figure 39. Liquid: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Powder: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Semi-Solid: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
Figure 43. General: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Disease Specific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
Figure 46. Oral: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Tube Feed: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Parenteral: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
Figure 50. Above 60 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. 18-60 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. 3-18 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Below 3 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
Figure 55. Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Retail Stores: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. E-Commerce: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Others: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. North America: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 60. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. North America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 62. US: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Canada: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Europe: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 65. Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. Europe: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 67. Germany: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. UK: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. France: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Italy: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Spain: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Netherlands: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Switzerland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 74. Poland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 75. Sweden: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 76. Belgium: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 77. Rest of Europe: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 78. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 79. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 80. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 81. China: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 82. Japan: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 83. India: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 84. Australia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 85. South Korea: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 86. Indonesia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 87. Thailand: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 88. Vietnam: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 89. Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 90. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 91. Middle East & Africa Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 92. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 93. Saudi Arabia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 94. South Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 95. UAE: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 96. Iran: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 97. Israel: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 98. Egypt: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 99. Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 100. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 101. South & Central America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 102. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 103. Mexico: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 104. Brazil: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 105. Argentina: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 106. Chile: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 107. Peru: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 108. Colombia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 109. Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 110. Impact of COVID-19 Pandemic on North American Country Markets
Figure 111. Impact of COVID-19 Pandemic in European Country Markets
Figure 112. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 113. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 114. Impact of COVID-19 Pandemic on South & Central American Country Markets
Figure 115. Growth Strategies in the Enteral and Parenteral Medical Nutrition Market
Figure 1. Enteral and Parenteral Medical Nutrition Market Segmentation
Figure 2. Enteral and Parenteral Medical Nutrition Market, By Region
Figure 3. Global Enteral and Parenteral Medical Nutrition Market Overview
Figure 4. Elderly Segment Held Largest Share of Indication Segment in Enteral and Parenteral Medical Nutrition Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Enteral and Parenteral Medical Nutrition Market, by Geography (US$ Million)
Figure 7. Global Enteral and Parenteral Medical Nutrition Market- Leading Country Markets (US$ Million)
Figure 8. Global Enteral and Parenteral Medical Nutrition Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis
Figure 16. Global Enteral and Parenteral Medical Nutrition Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Enteral and Parenteral Medical Nutrition Market– By Geography Forecast and Analysis – 2022 & 2028
Figure 18. Market Positioning of Key Players in Enteral and Parenteral Medical Nutrition Market
Figure 19. Market Share Analysis of Key Players in Enteral and Parenteral Medical Nutrition Market (2022)
Figure 20. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
Figure 21. Elderly: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. IBD: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. IBS: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Diabetes: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Cancer: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Alzheimer’s Disease: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Dementia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Renal Disease: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Liver Failure: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Post COVID-19: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Other Indications: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
Figure 36. Supplemental: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Sole Source: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
Figure 39. Liquid: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Powder: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Semi-Solid: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
Figure 43. General: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Disease Specific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
Figure 46. Oral: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Tube Feed: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Parenteral: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
Figure 50. Above 60 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. 18-60 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. 3-18 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Below 3 Years: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
Figure 55. Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Retail Stores: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. E-Commerce: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Others: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. North America: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 60. North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. North America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 62. US: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Canada: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Europe: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 65. Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. Europe: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 67. Germany: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. UK: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. France: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Italy: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Spain: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Netherlands: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Switzerland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 74. Poland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 75. Sweden: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 76. Belgium: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 77. Rest of Europe: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 78. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 79. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 80. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 81. China: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 82. Japan: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 83. India: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 84. Australia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 85. South Korea: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 86. Indonesia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 87. Thailand: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 88. Vietnam: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 89. Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 90. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 91. Middle East & Africa Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 92. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 93. Saudi Arabia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 94. South Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 95. UAE: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 96. Iran: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 97. Israel: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 98. Egypt: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 99. Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 100. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 101. South & Central America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 102. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 103. Mexico: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 104. Brazil: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 105. Argentina: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 106. Chile: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 107. Peru: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 108. Colombia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 109. Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 110. Impact of COVID-19 Pandemic on North American Country Markets
Figure 111. Impact of COVID-19 Pandemic in European Country Markets
Figure 112. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 113. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 114. Impact of COVID-19 Pandemic on South & Central American Country Markets
Figure 115. Growth Strategies in the Enteral and Parenteral Medical Nutrition Market
